FSLY Post-Earnings Revaluation — May 7, 2026
Regular close: $31.57 (May 6) | After-hours: $22.74 (-27.97%)
Q1 Actuals vs Expectations
| Metric | Result | Estimate | Beat |
|---|---|---|---|
| Revenue | $173M (+20% YoY) | $172M | +0.6% |
| EPS (non-GAAP) | $0.13 | $0.09 | +50% |
| Adj. Operating Income | $19.1M (11.1% margin) | $16.3M | +17% |
| Security revenue | $38.8M (+47% YoY) | — | blowout |
| RPO | $369M (+63%) | — | blowout |
| NRR | 113% | — | improving |
| Gross margin | 65.1% (record) | — | new high |
| FCF | $4.1M (2.4% margin) | — | weak, -3.3pp YoY |
Raised FY26 Guidance
| Old | New | Change | |
|---|---|---|---|
| Revenue | $700–720M | $710–725M | +1.1% |
| EPS | $0.23–0.29 | $0.27–0.33 | +15.4% |
| Q2 Revenue | — | $170–176M | vs est $170M |
| Q2 EPS | — | $0.05–0.08 | vs est $0.04 |
Why -28% on a Beat-and-Raise?
Textbook "sell the event" unwind on a stock that ran from $5.52 to $34.82 (+530% in 12 months). Three things killed it:
1. Guide raise was underwhelming
Revenue guidance midpoint lifted from $710M to $717.5M — only a 1.1% increase. After a 20% growth quarter with 47% security acceleration, the market wanted a bigger raise. A 1% bump signals management is sandbagging or genuinely uncertain about H2 durability.
2. FCF collapsed
Free cash flow came in at $4.1M in Q1, a 2.4% margin — down 3.3 percentage points year over year. The whole bull thesis pivoted on "first profitable year → FCF inflection." A 2.4% FCF margin on $173M revenue is barely positive, and the YoY regression signals the doubled capex (10–12% of revenue) is eating into cash conversion.
3. Pre-earnings run-up was extreme
FSLY ran from $23.76 (Apr 24) to $32.36 (May 6 close) — up 36% in 8 sessions into earnings. The stock surged ~17.7% on Tuesday alone. That's a setup for brutal profit-taking regardless of the print.
4. Insider selling overhang
Insiders sold $40.3M worth of shares in the past 90 days. At $32, institutional holders who rode the 5x from lows had massive incentive to exit.
Updated Valuation at $22.74
| Metric | At $32.36 (pre-print) | At $22.74 (AH) |
|---|---|---|
| Mkt Cap | ~$5.05B | ~$3.55B |
| EV/Rev 2026E ($717M) | ~6.7x | ~4.7x |
| Fwd P/E ($0.30 EPS) | ~108x | ~76x |
| EV/Adj EBITDA (est ~$120M) | ~40x | ~28x |
Trade Recap: Jun 18 $22.5C
- Entry: $4.10 (mid-April, stock ~$21.36)
- Exit: ~$6.15 pre-earnings (+50%)
- Outcome if held through: Call worth ~$1.50-2.00 at $22.74 stock with IV crush from ~130% to ~60-70%. Would have been a loss instead of +50%.
Key lesson: On a name that ran 530% in a year with 130% IV into earnings, taking profit pre-binary was the right call. The Q1 print was good — but "good" was already priced in at $32.
Is This a Buy Now?
Bull Case ($28-32 in 6 months)
- Q1 was objectively excellent: 20% growth, 47% security, 65% GM, 113% NRR, $369M RPO (+63%)
- New Fastly Agent Toolkit and AI capabilities = real product behind the agentic infrastructure narrative
- At 4.7x EV/Sales with 20% growth, cheaper than the April bottom
- Named a Leader in Forrester's Q1 2026 Edge Development Platforms report
Bear Case ($15-18)
- FCF margin regressing while capex doubles = potential value trap
- Guide raise was tiny — management may see H2 headwinds
- Two-year annualized revenue growth of 11.8% below five-year trend
- Still GAAP unprofitable (net loss $20.5M)
- Street consensus PT $21.43 — stock now at that level
- $40M insider selling in 90 days
Verdict
The print was good, not great. Revenue/EPS beats don't matter when FCF goes the wrong way and the guide raise is token. At $22.74, valuation is more reasonable — but the stock needs to prove FCF can scale with revenue before the next leg up.
Re-entry framework: If stock gaps to $22-23 and holds with volume tapering, a fresh Jun 18 $22.5C at ~$1.50-2.00 has far better risk/reward at depressed IV (breakeven ~$24-24.50 vs $26.60 last time). More conservative approach: wait for $20 support test and revisit after Q2.
Not investment advice. Analysis for educational purposes only.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.